Document is current
Any future updates will be listed below
-
Authors
Bruner, Kassandra R.
Byington, Isabella R.
Marx, Tyler J.
Vasileva, Anastasiia
Fletcher, Temara
Ghimire, Susma
Zappia, India J.
Shaju, Yashika
Zeng, Janan
Wachsmuth, Hallie R.
Carlyon, Thadeus W.
Besselsen, David G.
Drucker, Daniel J.
Duca, Frank A.
Stern, Jennifer H. https://orcid.org/0000-0002-5336-1358
-
Funding
Funding for this research was provided by:
National Institute on Aging (R00AG055649, R56AG079924, R01AG079924)
Arizona Biomedical Research Commission (ADHS-RFGA2022-010-04)
- License Information
-
More Information
Article History
Received: 16 May 2025
Accepted: 5 September 2025
First Online: 25 September 2025
Declarations
:
: All authors, except for DJD, declare no competing interests. DJD has received consulting fees from Anylam, Amgen, AstraZeneca Inc., Crinetics, Insulet, Kallyope, Metsara, and Pfizer Inc. and speaking fees from Novo Nordisk Inc. Mount Sinai Hospital has received investigator-initiated grant support from Amgen, Eli Lilly Inc., Novo Nordisk, Pfizer, and Zealand Pharmaceuticals Inc. to support preclinical studies in the Drucker laboratory. None of this grant support for DJD is related to studies of glucagon action.
